NEW YORK–(BUSINESS WIRE)–Axiom Global Inc. today announced it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed […]

SAN FRANCISCO–(BUSINESS WIRE)–Levi Strauss & Co. (LS&Co.) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a […]

SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the […]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Harpoon Therapeutics, Inc. (“Harpoon”), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today the pricing of its initial public offering of […]

SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced […]

NEW YORK–(BUSINESS WIRE)–RMG Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit. The units will be listed on the […]

SAN FRANCISCO–(BUSINESS WIRE)–Palantir has been successfully shifting its revenue stream from government contracts to large business subscriptions. As a result, increased profitability could position Palantir in the next 12 months […]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the pricing of its […]

LOS ANGELES–(BUSINESS WIRE)–Gores Metropoulos, Inc. (the “Company”), a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar […]

NEW YORK–(BUSINESS WIRE)–Pivotal Acquisition Corp. (NYSE: PVT.U) (the “Company”) announced today that it closed its initial public offering of 23,000,000 units, including the full 3,000,000 units subject to the underwriters’ […]